Personalized network-based treatments in oncology

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Personalized network-based treatments in oncology. / Robin, X; Creixell, P; Radetskaya, O; Santini, C C; Longden, J; Linding, Rune.

In: Clinical Pharmacology and Therapeutics, Vol. 94, No. 6, 12.2013, p. 646-650.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Robin, X, Creixell, P, Radetskaya, O, Santini, CC, Longden, J & Linding, R 2013, 'Personalized network-based treatments in oncology', Clinical Pharmacology and Therapeutics, vol. 94, no. 6, pp. 646-650. https://doi.org/10.1038/clpt.2013.171

APA

Robin, X., Creixell, P., Radetskaya, O., Santini, C. C., Longden, J., & Linding, R. (2013). Personalized network-based treatments in oncology. Clinical Pharmacology and Therapeutics, 94(6), 646-650. https://doi.org/10.1038/clpt.2013.171

Vancouver

Robin X, Creixell P, Radetskaya O, Santini CC, Longden J, Linding R. Personalized network-based treatments in oncology. Clinical Pharmacology and Therapeutics. 2013 Dec;94(6):646-650. https://doi.org/10.1038/clpt.2013.171

Author

Robin, X ; Creixell, P ; Radetskaya, O ; Santini, C C ; Longden, J ; Linding, Rune. / Personalized network-based treatments in oncology. In: Clinical Pharmacology and Therapeutics. 2013 ; Vol. 94, No. 6. pp. 646-650.

Bibtex

@article{cd3ac04784b44cf391d8f6dd3d17125f,
title = "Personalized network-based treatments in oncology",
abstract = "Network medicine aims at unraveling cell signaling networks to propose personalized treatments for patients suffering from complex diseases. In this short review, we show the relevance of network medicine to cancer treatment by outlining the potential convergence points of the most recent technological and scientific developments in both drug design and signaling network analysis.",
keywords = "Animals, Antineoplastic Combined Chemotherapy Protocols, Biological Markers, Drug Design, Humans, Individualized Medicine, Molecular Targeted Therapy, Neoplasms, Protein Interaction Maps, Protein Processing, Post-Translational, Signal Transduction, Systems Biology",
author = "X Robin and P Creixell and O Radetskaya and Santini, {C C} and J Longden and Rune Linding",
year = "2013",
month = dec,
doi = "10.1038/clpt.2013.171",
language = "English",
volume = "94",
pages = "646--650",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "JohnWiley & Sons, Inc.",
number = "6",

}

RIS

TY - JOUR

T1 - Personalized network-based treatments in oncology

AU - Robin, X

AU - Creixell, P

AU - Radetskaya, O

AU - Santini, C C

AU - Longden, J

AU - Linding, Rune

PY - 2013/12

Y1 - 2013/12

N2 - Network medicine aims at unraveling cell signaling networks to propose personalized treatments for patients suffering from complex diseases. In this short review, we show the relevance of network medicine to cancer treatment by outlining the potential convergence points of the most recent technological and scientific developments in both drug design and signaling network analysis.

AB - Network medicine aims at unraveling cell signaling networks to propose personalized treatments for patients suffering from complex diseases. In this short review, we show the relevance of network medicine to cancer treatment by outlining the potential convergence points of the most recent technological and scientific developments in both drug design and signaling network analysis.

KW - Animals

KW - Antineoplastic Combined Chemotherapy Protocols

KW - Biological Markers

KW - Drug Design

KW - Humans

KW - Individualized Medicine

KW - Molecular Targeted Therapy

KW - Neoplasms

KW - Protein Interaction Maps

KW - Protein Processing, Post-Translational

KW - Signal Transduction

KW - Systems Biology

U2 - 10.1038/clpt.2013.171

DO - 10.1038/clpt.2013.171

M3 - Journal article

C2 - 23995267

VL - 94

SP - 646

EP - 650

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 6

ER -

ID: 122676190